Improvement in neutrophil and monocyte function during highly active antiretroviral treatment of HIV-1-infected patients

AIDS

Volumn 13, Issue 8, 1999, Pages 883-890

  Mastroianni, Claudio M ^a   Lichtner, Miriam ^a   Mengoni, Fabio ^a   D'Agostino, Claudia ^a   Forcina, Gabriele ^a   D'Ettorre, Gabriella ^a   Santopadre, Paola ^a   Vullo, Vincenzo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Anti HIV 1 therapy; Innate immunity; Monocytes; Neutrophils

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; INDINAVIR; PEPTIDE; PHORBOL 13 ACETATE 12 MYRISTATE; RITONAVIR;

ADULT; AGED; ARTICLE; CANDIDA ALBICANS; CHEMOLUMINESCENCE; CLINICAL ARTICLE; CYTOTOXICITY; FEMALE; FUNGICIDAL ACTIVITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MALE; MONOCYTE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; RESPIRATORY BURST; T LYMPHOCYTE SUBPOPULATION;

ADULT; AGED; ANTI-HIV AGENTS; CANDIDA ALBICANS; CHEMILUMINESCENT MEASUREMENTS; CHEMOTAXIS, LEUKOCYTE; DRUG THERAPY, COMBINATION; FEMALE; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HIV-1; HUMANS; MALE; MIDDLE AGED; MONOCYTES; NEUTROPHILS; PHAGOCYTOSIS; PROSPECTIVE STUDIES; RESPIRATORY BURST; REVERSE TRANSCRIPTASE INHIBITORS;

EID: 0033007068     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199905280-00003     Document Type: Article

References (40)

1. Centers for Diseases Control and Prevention. Update: trends in AIDS incidence 1996. MMWR Morb Mortal Wkly Rep 1997, 46:961-867.
2. Powderly WG, Landay A, Lederman MM. Recovery of the immune system with antiretroviral therapy. The end of opportunism? JAMA 1998, 280:72-77.
3. Meltzer MS, Skillman DR, Gomatos PJ, Kalter DC, Gendelman HE. Role of mononuclear phagocytes in the pathogenesis of human immunodeficiency virus infection. Annu Rev Immunol 1990, 8:169-194.
4. Crowe SM, Vardaxis NJ, Kent SJ, et al. HIV infection of monocyte-derived macrophages in vitro reduces phagocytosis of Candida albicans. J Leukoc Biol 1994, 56:318-327.
5. Vecchiarelli A, Monari C, Baldelli F, et al. Beneficial effect of recombinant human granulocyte colony-stimulating factor on fungicidal activity of polymorphonuclear leukocytes from patients with AIDS. J Infect Dis 1995, 171:1448-1454.
6. Laursen AL, Rungby J, Andersen PL. Decreased activation of the respiratory burst in neutrophils from AIDS patients with previous Pneumocystis carinii pneumonia. J Infect Dis 1995, 172:497-505.
7. Biggs B-A, Hewish M, Kent S, Hayes K, Crowe SM. HIV-1 infection impairs phagocytosis and killing of Toxoplasma gondii. J Immunol 1995, 154:6132-6139.
8. Chalurvedi S, Frame P, Newman SL. Macrophages from human immunodeficiency virus-positive persons are defective in host defense against Histoplasma capsulatum. J Infect Dis 1995, 171:320-327.
9. Harrison TS, Levitz SM. Mechanisms of impaired anticryptococcal activity of monocytes from donors infected with human immunodeficiency virus. J Infect Dis 1997, 176:537-540.
10. Newman GW, Guarnaccia JR, Remold HG, Kazanjian PH Jr. Cytokines enhance neutrophils from human immunodeficiency virus-negative donors and AIDS patients to inhibit the growth of Mycobacterium avium in vitro. J Infect Dis 1997, 175:891-900.
11. Vullo V, Mastroianni CM, Lichtner M, et al. Rhodococcus equi infection of monocytes/macrophages from human immunodeficiency (HIV)-infected patients and healthy individuals: evaluation of intracellular killing and nitric oxide production. FEMS Immunol Med Microbiol 1998, 21:11-17.
12. Shyur S-D, Hill HR. Polymorphonuclear leukocyte function in HIV, In Immunology of HIV infection. Edited by Gupta S. New York: Plenum Press; 1996:377-386.
13. Trial J, Birdsall H, Hallum JA, et al. Phenotypic and functional changes in peripheral blood monocytes during progression of human immunodeficiency virus infection. Effects of soluble immune complexes, cytokines, subcellular particulates from apoptotic cells, and HIV-1 encoded proteins on monocyte phagotytic function, oxidative burst, transendothelial migration, and cell surface phenotype. J Clin Invest 1995, 95:1690-1701.
14. Wahl SM, Orenstein JM. Macrophage functions in HIV-1 infection. In Immunology of HIV infection. Edited by Gupta S. New York: Plenum Press: 1996:303-336.
15. Boyum A. Isolation of leukocytes from human blood. Scand J Clin Lab Invest 1968, 21 (Suppl. 97):77-80.
16. Lehrer RI, Cline MJ. Interaction of C. albicans with human leukocytes and serum. J Bacteriol 1969, 98:996-1002.
17. Lederman MM, Connick E, Landay A, et al. Immunologic responses associated with 12 weeks of combination antiretroviral therapy consisting of zidovudine, lamivudine, and ritonavir: results of AIDS clinical trials group protocol 315. J Infect Dis 1998, 178:70-79.
18. Kelleher AD, Carr A, Zaunders J, Cooper DA. Alterations in the immune response of human immunodeficiency virus (HIV)-infected subjects treated with an HIV-specific protease inhibitor, ritonavir. J Infect Dis 1996, 173:321-329.
19. Angel JB, Kumar A, Parato K, et al. Improvement in cell-mediated immune function during potent anti-human immunodeficiency virus therapy with ritonavir plus saquinavir. J lnfect Dis 1998, 177:898-904.
20. Flo RW, Naess A, Nilsen A, Harthug S, Solberg CO. A longitudinal study of phagocyte function in HIV-infected patients. AIDS 1994, 8:771-777.
21. Lazzarin A, Uberti Foppa C, Galli C, et al. Impairment of polymorphonuclear leucocyte function in patients with acquired immunodeficiency syndrome and with lymphoadenopathy syndrome. Clin Exp Immunol 1986, 65:105-111.
22. Nielsen H, Kharami A, Faber V. Blood monocyte and neutrophil functions in the acquired immune deficiency syndrome. Scand J Immunol 1986, 24:291-296.
23. Martin LS, Spira TJ, Orloff SL, Holman RC. Comparison of methods for assessing chemotaxis and polymorphonuclear leukocytes isolated from patients with AIDS or AIDS-related conditions. J Leukoc Biol 1988, 44:331-366.
24. Roilides E, Mertins S, Eddy J, Walsh TJ, Pizzo PA, Rubin M. Impairment of neutrophil chemotactic and bactericidal function in children infected with human immunodeficiency virus type 1 and partial reversal after in vitro exposure to granulocyte-macrophage colony-stimulating factor. J Pediatr 1990, 117:531-540.
25. Ellis M, Gupta S, Galant S, et al. Impaired neutrophil function in patients with AIDS or AIDS-related complex; a comprehensive evaluation. J Infect Dis 1988, 158:1268-1276.
26. Murphy PM, Lane C, Fauci AS, Gallin JI. Impairment of neutrophil bactericidal capacity in patients with AIDS. J Infect Dis 1988, 158:627-630.
27. Roilides E, Holmes A, Blake C, Pizzo PA, Walsh TJ. Defective antifungal activity of monocyte-derived macrophages from human immunodeficiency virus-infected children against Aspergillus fumigatus. J Infect Dis 1993, 168:1562-1565.
28. Monari C, Baldelli F, Pietrella D, et al. Monocyte dysfunction in patients with acquired immunodeficiency syndrome (AIDS) versus Cryptococcus neoformans. J Infect 1997, 35:257-263.
29. Mitola S, Sozzani S, Luini W, et al. Tat-human immunodeficiency virus-1 induces human monocyte chemotaxis by activation of vascular-endothelial growth factor receptor-1. Blood 1994, 90:1365-1372.
30. Pietrella D, Monari C, Retini C, Palazzetti B, Bistoni F, Vecchiarelli A. Human immunodeficiency virus type 1 envelope protein gp120 impairs intracellular antifungal mechanisms in human monocytes. J Infect Dis 1998, 177:347-354.
31. Tascini C, Baldelli F, Monari C, et al. Inhibition of fungicidal activity of polymorphonuclear leukocytes from HIV-infected patients by interleukin (IL)-4 and IL-10. AIDS 1996, 10:477-483.
32. Meier-Osusky I, Schoedon G, Bauer F, Schneemann M, Schaffner A. Comparison of the antimicrobial activity of deactivated human macrophages challenged with Aspergillus fumigatus and Listeria monocytogenes. J Infect Dis 1996, 174:651-654.
33. Spear GT, Kessler HA, Rothberg L, Phair J, Landay AL. Decreased oxidative burst activity of monocytes from asymptomatic HIV-infected patients. Clin Immunol Immunopathol 1990, 54:184-191.
34. Pitrak DL, Bak PM, DeMarais P, Novak RM, Andersen BB. Depressed neutrophil superoxide production in human immunodeficiency virus infection. J Infect Dis 1993, 167:1406-1410.
35. Gabrilovich D, Ivanova L, Serebrovskaya L, Shepeleva G, Pokrovsky V. Clinical significance of neutrophil functional activity in HIV infection. Scand Infect Dis 1994, 26:41-47.
36. Bandres JC, Trial J, Musher DM, Rossen RD. Increased phagocytosis and generation of reactive oxygen products by neutrophils and monocytes of men with stage I human immunodeficiency virus infection. J Infect Dis 1993, 168:75-73.
37. Roilides E, Venzon D, Pizzo PA, Rubin M. Effects of antiretroviral dideoxynucleosides on polymorphonuclear leukocyte function. Antimicrob Agents Chemother 1990, 34:1672-1677.
38. Bugelski PJ, Kaplan JM, Hart TK. Effect of a human immunodeficiency virus protease inhibitor on human monocyte function. AIDS Res Human Retroviruses 1992, 8:1951-1958.
39. Li TS, Tubiana R, Calvez V, Ait Mohand H, Autran B. Long-lasting recovery in CD4 T-cell function and viral-load reductyyion after highly active antiretroviral therapy in advanced HIV-1 disease. Lancet 1998, 351:1682-1686.
40. + T-lymphocyte responses after ganciclovir and highly active antiretroviral therapy in individuals infected with HIV-1. Nat Med 1998, 4:953-956.